GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines...
GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) currently trades at a P/E ratio of 18.07 (historical range: 17.83–19.34, median: 18.56), placing it at the 3th percentile — cheap relative to its history, P/S ratio of 3.16 (range: 3.12–3.38, 3th percentile — cheap relative to its history), EV/EBITDA of 14.82 (range: 14.66–15.74, 3th percentile).
GSK plc American Depositary Shares (Each representing two Ordinary Shares) appears significantly undervalued relative to its historical range, trading at depressed multiples across most metrics.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 18.07 | 17.83 | 18.56 | 19.34 | 3th | cheap relative to its history |
| P/S Ratio | 3.16 | 3.12 | 3.25 | 3.38 | 3th | cheap relative to its history |
| EV/EBITDA | 14.82 | 14.66 | 15.18 | 15.74 | 3th | cheap relative to its history |